Glenmede Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,743
| Closed | -$919K | – | 1376 |
|
|
2024
Q4 | $919K | Sell |
24,743
-13,141
| -35% | -$488K | ﹤0.01% | 748 |
|
|
2024
Q3 | $1.84M | Buy |
37,884
+22,439
| +145% | +$1.09M | 0.01% | 583 |
|
|
2024
Q2 | $618K | Sell |
15,445
-1,591
| -9% | -$63.6K | ﹤0.01% | 825 |
|
|
2024
Q1 | $748K | Sell |
17,036
-1,080
| -6% | -$47.4K | ﹤0.01% | 791 |
|
|
2023
Q4 | $1.12M | Buy |
18,116
+7,672
| +73% | +$475K | 0.01% | 661 |
|
|
2023
Q3 | $480K | Sell |
10,444
-27
| -0.3% | -$1.24K | ﹤0.01% | 854 |
|
|
2023
Q2 | $393K | Hold |
10,471
| – | – | ﹤0.01% | 901 |
|
|
2023
Q1 | $393K | Sell |
10,471
-29
| -0.3% | -$1.09K | ﹤0.01% | 906 |
|
|
2022
Q4 | $294K | Sell |
10,500
-365
| -3% | -$10.2K | ﹤0.01% | 989 |
|
|
2022
Q3 | $305K | Buy |
10,865
+318
| +3% | +$8.93K | ﹤0.01% | 954 |
|
|
2022
Q2 | $366K | Buy |
+10,547
| New | +$366K | ﹤0.01% | 948 |
|
|
2020
Q4 | – | Sell |
-104
| Closed | -$1K | – | 1235 |
|
|
2020
Q3 | $1K | Sell |
104
-98
| -49% | -$942 | ﹤0.01% | 2316 |
|
|
2020
Q2 | $4K | Sell |
202
-474
| -70% | -$9.39K | ﹤0.01% | 2108 |
|
|
2020
Q1 | $13K | Hold |
676
| – | – | ﹤0.01% | 2290 |
|
|
2019
Q4 | $13K | Buy |
676
+131
| +24% | +$2.52K | ﹤0.01% | 2290 |
|
|
2019
Q3 | $10 | Sell |
545
-10
| -2% | – | ﹤0.01% | 2335 |
|
|
2019
Q2 | $11 | Sell |
555
-42
| -7% | -$1 | ﹤0.01% | 2324 |
|
|
2019
Q1 | $12 | Hold |
597
| – | – | ﹤0.01% | 2285 |
|
|
2018
Q4 | $11 | Buy |
+597
| New | +$11 | ﹤0.01% | 2223 |
|